Critical Reviews in Clinical Laboratory Sciences

Papers
(The median citation count of Critical Reviews in Clinical Laboratory Sciences is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-06-01 to 2024-06-01.)
ArticleCitations
The COVID-19 pandemic777
Biomarkers associated with COVID-19 disease progression537
COVID-19: from an acute to chronic disease? Potential long-term health consequences221
Current concepts and advances in biomarkers of acute kidney injury83
The COVID-19 pandemic: viral variants and vaccine efficacy67
Effects of age, sex, serostatus, and underlying comorbidities on humoral response post-SARS-CoV-2 Pfizer-BioNTech mRNA vaccination: a systematic review59
Vitamin B12status in health and disease: a critical review. Diagnosis of deficiency and insufficiency – clinical and laboratory pitfalls59
Vitamin D: sources, physiological role, biokinetics, deficiency, therapeutic use, toxicity, and overview of analytical methods for detection of vitamin D and its metabolites57
Potential value and impact of data mining and machine learning in clinical diagnostics54
A summary of the diagnostic and prognostic value of hemocytometry markers in COVID-19 patients51
Molecular diagnostic assays for COVID-19: an overview47
The laboratory’s role in combating COVID-1936
Recent evolutions of machine learning applications in clinical laboratory medicine26
The molecular structure and biological functions of RNA methylation, with special emphasis on the roles of RNA methylation in autoimmune diseases24
Breathing new life into clinical testing and diagnostics: perspectives on volatile biomarkers from breath23
The role of soluble receptor for advanced glycation end-products (sRAGE) in the general population and patients with diabetes mellitus with a focus on renal function and overall outcome23
Molecular tissue profiling by MALDI imaging: recent progress and applications in cancer research23
Implementation of patient-based real-time quality control22
What the lab can and cannot do: clinical interpretation of drug testing results20
Nucleic acid-based electrochemical biosensors for rapid clinical diagnosis: advances, challenges, and opportunities20
Procalcitonin for individualizing antibiotic treatment: an update with a focus on COVID-1920
Liquid biopsy with cell free DNA: new horizons for prostate cancer18
T helper cells in depression: central role of Th17 cells18
The potential impact of salivary peptides in periodontitis18
Choice of SARS-CoV-2 diagnostic test: challenges and key considerations for the future17
Oligoclonal bands: clinical utility and interpretation cues17
The role of kallikreins in inflammatory skin disorders and their potential as therapeutic targets16
Quantifying RNA modifications by mass spectrometry: a novel source of biomarkers in oncology15
Multiple biomarker approach for the diagnosis and therapy of rheumatoid arthritis15
CRISPR-based biosensing systems: a way to rapidly diagnose COVID-1915
Immunologic evaluation and genetic defects of apoptosis in patients with autoimmune lymphoproliferative syndrome (ALPS)15
Identifying and overcoming barriers to harmonize newborn screening programs through consensus strategies14
Smartphone technology facilitates point-of-care nucleic acid diagnosis: a beginner’s guide13
DropWise: current role and future perspectives of dried blood spots (DBS), blood microsampling, and their analysis in sports drug testing13
Systematic review and meta-analysis of C-reactive protein as a biomarker in breast cancer13
Clinical utility of procalcitonin and its association with pathogenic microorganisms12
Lean and Six Sigma as continuous quality improvement frameworks in the clinical diagnostic laboratory12
Progress in understanding COVID-19: insights from the omics approach12
Presentation and formatting of laboratory results: a narrative review on behalf of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group “postanalytical phase” (WG11
Development of circulating microRNA-based biomarkers for medical decision-making: a friendly reminder of what should NOT be done11
Personalized reference intervals: from theory to practice11
Disruptive innovations in the clinical laboratory: catching the wave of precision diagnostics10
Screening and diagnosis of inherited platelet disorders9
Novel biomarkers in Alzheimer’s disease using high resolution proteomics and metabolomics: miRNAS, proteins and metabolites9
Evidence-based approach to setting delta check rules9
Evaluation of pathophysiological relationships between renin-angiotensin and ACE-ACE2 systems in cardiovascular disorders: from theory to routine clinical practice in patients with heart failure9
Impact of body mass index on growth hormone stimulation tests in children and adolescents: a systematic review and meta-analysis9
Oxidized LDL-regulated microRNAs for evaluating vascular endothelial function: molecular mechanisms and potential biomarker roles in atherosclerosis8
Current understanding and controversies on the clinical implications of fibroblast growth factor 218
Metabolomics of asthma, COPD, and asthma-COPD overlap: an overview8
Clot activators and anticoagulant additives for blood collection. A critical review on behalf of COLABIOCLI WG-PRE-LATAM7
Physiological and metabolic adaptations in pregnancy: importance of trimester-specific reference intervals to investigate maternal health and complications7
Free thyroxine measurement in clinical practice: how to optimize indications, analytical procedures, and interpretation criteria while waiting for global standardization7
Evaluating thyroid function in pregnant women7
Clinical features and diagnostic tools in idiopathic inflammatory myopathies7
New biomarkers in acute kidney injury7
Von Willebrand factor and disease: a review for laboratory professionals6
Overutilization in laboratory medicine: tackling the problem with quality improvement science6
Biomarkers of disease in human nails: a comprehensive review6
Cardiovascular benefit of SGLT2 inhibitors6
Reference intervals: past, present, and future6
Current status and challenges in establishing reference intervals based on real-world data5
Emerging applications of machine learning in genomic medicine and healthcare5
Cytogenetic and molecular genetic methods for chromosomal translocations detection with reference to the KMT2A/MLL gene5
Pre-analytical conditions and implementation of quality control steps in liquid biopsy analysis5
Technical quality assurance and quality control for medical laboratories: a review and proposal of a new concept to obtain integrated and validated QA/QC plans5
Immunohistochemistry features and molecular pathology of appendiceal neoplasms5
Complement testing in the clinical laboratory5
Using a systematic approach to strategic innovation in laboratory medicine to bring about change5
0.02005410194397